Institut Suisse de Recherche Expérimentale sur le Cancer

Blocking sugar metabolism slows lung tumour growth

Published:23.06.20 — Treatments that block two sugar-transporting proteins could help slow the growth of lung tumours, new research from EPFL suggests.

How accurate are transcription factor binding-site motifs?

Published:12.06.20 — An international team led by researchers from EPFL and the Russian Academy of Sciences have undertaken a comprehensive benchmarking study to assess the predictive performance of publicly available transcription factor binding site motifs.

A better model for neutrophil-related diseases

Published:02.06.20 — Neutrophils are critical immune cells for antimicrobial defense, but they can exacerbate a number of diseases, perhaps including COVID-19. The traditional approaches to study neutrophils in animal models are limited in specificity and effectiveness. EPFL scientists have now identified the problem and have developed a new, optimized model for studying the role of neutrophils in the context of disease.